Age-Related Cognitive Deficits and Neurotransmitters. In: Peters A, Morrison JH, editors. Cerebral Cortex. Boston: Springer US; 1999. pp. 89-110. [DOI: 10.1007/978-1-4615-4885-0_5]

The aging brain: sleep, the circadian clock and exercise

Aging is a multifactorial process likely stemming from damage accumulation and/or a decline in maintenance and repair mechanisms in the organisms that eventually determine their lifespan. In our review, we focus on the morphological and functional alterations that the aging brain undergoes affecting sleep and the circadian clock in both human and rodent models. Although both species share mammalian features, differences have been identified on several experimental levels, which we outline in this review. Additionally, we delineate some challenges on the preferred analysis and we suggest that a uniform route is followed so that findings can be smoothly compared. We conclude by discussing potential interventions and highlight the influence of physical exercise as a beneficial lifestyle intervention, and its effect on healthy aging and longevity. We emphasize that even moderate age-matched exercise is able to ameliorate several aging characteristics as far as sleep and circadian rhythms are concerned, independent of the species studied.

Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals

The working-memory functions of the prefrontal cortex (PFC) are improved by stimulation of postsynaptic, alpha2A-adrenoceptors, especially in aged animals with PFC cognitive deficits. Thus, the alpha2A-adrenoceptor agonist, guanfacine, greatly improves working-memory performance in monkeys and rats following systemic administration or intra-PFC infusion. Alpha2A-adrenoceptors are generally coupled to Gi, which can inhibit adenylyl cyclases and reduce the production of cAMP. However, no study has directly examined whether the working-memory enhancement observed with guanfacine or other alpha2A-adrenoceptor agonists results from cAMP inhibition. The current study confirmed this hypothesis in both rats and monkeys, showing that treatments that increase cAMP-mediated signaling block guanfacine's beneficial effects. In aged rats, guanfacine was infused directly into the prelimbic PFC and was challenged with co-infusions of the cAMP analog, Sp-cAMPS. In aging monkeys, systemically administered guanfacine was challenged with the phosphodiesterase 4 inhibitor, rolipram, using intramuscular doses known to have no effect on their own. In both studies, agents that mimicked the actions of cAMP (rats) or increased endogenous cAMP (monkeys) completely blocked the enhancing effects of guanfacine on working-memory performance. These results are consistent with alpha2A-adrenoceptor stimulation enhancing PFC working-memory function via inhibition of cAMP-mediated signaling.

Aging of Brain: Role of Estrogen

The brain undergoes many structural and functional changes during aging. Some of these changes are regulated by estrogens which act mainly through their intracellular receptors, estrogen receptor ERalpha and ERbeta. The expression of these receptors is regulated by several factors including their own ligand estrogen, and others such as growth hormone and thyroid hormone. The levels of these factors decrease during aging which in turn influence estrogen signaling leading to alterations in brain functions. In the present paper, we review the effects of aging on brain structure and function, and estrogen action and signaling during brain aging. The findings suggest key role of estrogen in the maintenance of brain functions during aging.

Protein kinase A as a therapeutic target for memory disorders: rationale and challenges

cAMP-dependent protein kinase A (PKA) signaling has a key role in memory processes and has been identified as a potential therapeutic target for memory disorders. The activation of PKA signaling is crucial for the consolidation of long-term memories dependent on the hippocampus and/or the amygdala, By contrast, initial studies indicate that cAMP-PKA activation might impair the working memory and executive functions of the prefrontal cortex. Furthermore, PKA activation in the nucleus accumbens might increase sensitivity to addiction. These complexities must be heeded when designing medications aimed at altering PKA activity. PKA might be most practical as a therapeutic target in disorders with global alterations in cAMP-PKA activity due to genetic or environmental factors.

Memory and Aging in Context

Much research has indicated that aging is accompanied by decrements in memory performance across a wide variety of tasks and situations. A dominant perspective is that these age differences reflect normative changes in the integrity and efficiency of the information-processing system. Contextual perspectives of development, however, argue for consideration of a broader constellation of factors as determinants of both intraindividual change and interindividual variation in memory functioning. The validity of the contextual perspective in characterizing the relationship between aging and memory is examined through a review of studies exploring a variety of alternative mechanisms associated with age differences in performance. It is concluded that a more multidimensional approach to the study of aging and memory is warranted.

Noradrenergic blockade and numeric working memory in humans

To investigate the noradrenergic modulation of working memory in humans single doses of two beta-blockers [either 25 mg of propranolol (lipophilic) or 50 mg of atenolol (hydrophilic)] or placebo were administered to young healthy volunteers (16 subjects per drug condition) performing a numerical working memory task that requires either short-term maintenance or maintenance plus manipulation of visually presented four-number sequences. Higher manipulation costs (i.e. process-specific slowing of reaction times in the manipulation conditions compared to the control condition) were observed after propranolol but not after atenolol. The propranolol effect was mainly observed in subjects with low emotional arousal (i.e. low state anxiety rating at baseline). Because both beta-blockers induced a comparable decrease of blood pressure and pulse, the propranolol effect on the 'working component' of working memory is considered to be a central, presumably prefrontal one.

Structural changes that occur during normal aging of primate cerebral hemispheres

Human and non-human primates show cognitive decline during normal aging. Originally, the decline was attributed to a loss of cortical neurons, but recent studies have shown there is no significant cortical neuronal loss with age. Neurons acquire pigment, but the only other obvious changes are in layer 1 of neocortex. Layer 1 becomes thinner as apical tufts of pyramidal cells lose branches, as well as synapses, and at the same time the glial limiting membrane thickens. How dendrites and synapses in deep layers are affected by age is uncertain, but there are decreases in the levels of some neurotransmitters and receptors. Throughout the brain myelin sheaths show signs of breakdown. This may contribute to cognitive decline because it would cause a slowing of conduction along nerve fibers, disrupting the timing in neuronal circuits. Concomitantly, the myelin-forming oligodendrocytes develop swellings along their processes and gain dense inclusions. Microglial cells and astrocytes accumulate large amounts of phagocytosed material with age, although the origins of this material are not known.